Longevity pharmaceutical company Enlivex secures $21 million in debt financing.

CoinFeed reported on March 24th that Enlivex, a longevity medicine and RAIN token treasury, announced it has secured $21 million in debt financing from New York-based institutional investor The Lind Partners. The company stated it will continue its prediction market token treasury strategy, adding approximately 3 billion new RAIN tokens to support its operational plans. Enlivex, a Nasdaq-listed company, is developing therapies for joint diseases such as osteoarthritis and holds a large RAIN position as its digital asset treasury. RAIN is a decentralized prediction market protocol token deployed on the Arbitrum network, whose protocol uses AI to determine outcomes and employs a buyback and burn mechanism.